The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Compared to the only other approved device for TB detection in people living with HIV, the new FujiLAM point-of-care test offers superior diagnostic sensitivity.
The treat-all policy will only succeed if people keep taking their HIV treatment. It is important to motivate people who started treatment while they were still feeling well.
Increasing numbers of people co-infected with HIV and hepatitis C (HCV) are accessing treatment for HCV as antivirals become more effective – but challenges beyond increasing access, remain.
New research shows that food insecurity can impact treatment outcomes for people living with HIV and hepatitis C (HCV) co-infection.
A new low-cost, low-tech method for predicting an adult’s risk of developing tuberculosis (TB) could represent a major step forward for TB prevention.
Although the risk of developing cancer is decreasing for people living with HIV as antiretroviral treatment (ART) improves, it remains higher for certain cancers – and as ART expands, this burden is expected to grow.
The proportion of people affected by the leading cause of death for people living with HIV, tuberculosis, is on the rise in Europe.
Gay men living with HIV are 37 times more likely to develop anal cancer than HIV-negative gay men, but a lack of guidelines means these men don’t get screened.
Expanding access to treatment for people living with HIV is shown to decrease tuberculosis (TB) incidence – but it is not the silver bullet.
Study in South Africa and Burkina Faso shows that simple HPV screening could help save lives in places with limited health infrastructure.
